Podcasts about Naloxone

In this episode, I divide Suboxone, buprenorphine, and naloxone into syllables, tell you which syllables to emphasize, and share my sources. As a bonus, I share my Suboxone mispronunciation from ~2002. The written pronunciations are below and in the show notes on https://www.thepharmacistsvoice.com/podcast.   Note: we don't cover pharmacology in this series. Just pronunciations. The FULL show notes are available at https://www.thepharmacistsvoice.com/podcast.    Suboxone = sub-OX-own Emphasize the second syllable, OX (which sounds like “BOX” when you say Suboxone fast) Sources: For the written pronunciation, read the medication guide for Suboxone https://www.suboxone.com/pdfs/medication-guide.pdf. Spoken pronunciations - google.com, m-w.com, or drugs.com.   buprenorphine = byoo pre NOR feen Emphasize NOR  Sources: Written - medlineplus.gov. Spoken - google.com, m-w.com, or drugs.com    naloxone = nal-OX-one  Emphasize OX (which sounds like “LOX” when you say naloxone fast) Sources: Written - medlineplus.gov. Spoken - google.com, m-w.com, or drugs.com    Thank for listening to the 59th episode in my drug pronunciation series!   If you'd like to recommend a drug name for this series, please reach out through the contact form on my website, thepharmacistsvoice.com.   If you know someone who would like to learn how to say Suboxone, buprenorphine, or naloxone, please share this episode with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   ⭐️ Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF   Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting).    Links for this episode Suboxone written pronunciation (accessed July 17, 2025) https://www.suboxone.com/pdfs/medication-guide.pdf  Buprenorphine written pronunciation (accessed July 17, 2025) https://medlineplus.gov/druginfo/meds/a605002.html Naloxone written pronunciation (accessed July 17, 2025) https://medlineplus.gov/druginfo/meds/a616003.html  Spoken pronunciations for all three drug names today: google.com, m-w.com, and drugs.com Note: I was unable to find the written pronunciations for buprenorphine and naloxone in the USP Dictionary Online. The USP Dictionary Online is my go-to resource for written generic drug pronunciations.    Other episodes in this series The Pharmacist's Voice Podcast Episode 337, Pronunciation Series Episode 58 (rosuvastatin)  The Pharmacist's Voice Podcast Episode 335, Pronunciation Series Episode 57 (QVAR) The Pharmacist's Voice Podcast Episode 333, Pronunciation Series Episode 56 (pantoprazole)  The Pharmacist's Voice Podcast Episode 330, Pronunciation Series Episode 55 (oxcarbazepine) The Pharmacist's Voice Podcast Episode 328, Pronunciation Series Episode 54 (nalmefene) The Pharmacist's Voice Podcast Episode 326, Pronunciation Series Episode 53 (Myrbetriq) The Pharmacist's Voice Podcast Episode 324, Pronunciation Series Episode 52 (liraglutide)  The Pharmacist's Voice Podcast Episode 322, Pronunciation Series Episode 51 (ketamine) The Pharmacist's Voice Podcast Episode 320, Pronunciation Series Episode 50 (Jantoven) The Pharmacist's Voice Podcast Episode 318, Pronunciation Series Episode 49 (ipratropium) The Pharmacist's Voice Podcast Episode 316, Pronunciation Series Episode 48 (hyoscyamine) The Pharmacist's Voice Podcast Episode 313, Pronunciation Series Episode 47 (guaifenesin) The Pharmacist's Voice Podcast Episode 311, Pronunciation Series Episode 46 (fluticasone) The Pharmacist's Voice Podcast Episode 309, Pronunciation Series Episode 45 (empagliflozin) The Pharmacist's Voice Podcast Episode 307, Pronunciation Series Episode 44 (dapagliflozin) The Pharmacist's Voice Podcast Episode 304, Pronunciation Series Episode 43 (cetirizine)  The Pharmacist's Voice Podcast Episode 302, Pronunciation Series Episode 42 (buspirone)  The Pharmacist's Voice Podcast Episode 301, Pronunciation Series Episode 41 (azithromycin) The Pharmacist's Voice Podcast Episode 298, Pronunciation Series Episode 40 (umeclidinium) The Pharmacist's Voice Podcast Episode 296, Pronunciation Series Episode 39 (Januvia)  The Pharmacist's Voice Podcast Episode 294, Pronunciation Series Episode 38 (Yasmin) The Pharmacist's Voice Podcast Episode 292, Pronunciation Series Episode 37 (Xanax, alprazolam) The Pharmacist's Voice Podcast Episode 290, Pronunciation Series Episode 36 (quetiapine)  The Pharmacist's Voice Podcast Episode 287, pronunciation series ep 35 (bupropion) The Pharmacist's Voice Podcast Episode 285, pronunciation series ep 34 (fentanyl) The Pharmacist's Voice Podcast Ep 281, Pronunciation Series Ep 33 levothyroxine (Synthroid) The Pharmacist's Voice ® Podcast Ep 278, Pronunciation Series Ep 32 ondansetron (Zofran) The Pharmacist's Voice ® Podcast Episode 276, pronunciation series episode 31 (tocilizumab-aazg) The Pharmacist's Voice ® Podcast Episode 274, pronunciation series episode 30 (citalopram and escitalopram) The Pharmacist's Voice ® Podcast Episode 272, pronunciation series episode 29 (losartan) The Pharmacist's Voice Podcast Episode 269, pronunciation series episode 28 (tirzepatide) The Pharmacist's Voice Podcast Episode 267, pronunciation series episode 27 (atorvastatin)  The Pharmacist's Voice Podcast Episode 265, pronunciation series episode 26 (omeprazole) The Pharmacist's Voice Podcast Episode 263, pronunciation series episode 25 (PDE-5 inhibitors) The Pharmacist's Voice Podcast Episode 259, pronunciation series episode 24 (ketorolac) The Pharmacist's Voice ® Podcast episode 254, pronunciation series episode 23 (Paxlovid) The Pharmacist's Voice ® Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacist's Voice Podcast ® episode 245, pronunciation series episode 21 (naltrexone/Vivitrol) The Pharmacist's Voice ® Podcast episode 240, pronunciation series episode 20 (levalbuterol) The Pharmacist's Voice ® Podcast episode 236, pronunciation series episode 19 (phentermine)  The Pharmacist's Voice ® Podcast episode 228, pronunciation series episode 18 (ezetimibe) The Pharmacist's Voice ® Podcast episode 219, pronunciation series episode 17 (semaglutide) The Pharmacist's Voice ® Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacist's Voice ® Podcast episode 211, pronunciation series episode 15 (Humira®) The Pharmacist's Voice ® Podcast episode 202, pronunciation series episode 14 (SMZ-TMP) The Pharmacist's Voice ® Podcast episode 198, pronunciation series episode 13 (carisoprodol) The Pharmacist's Voice ® Podcast episode 194, pronunciation series episode 12 (tianeptine) The Pharmacist's Voice ® Podcast episode 188, pronunciation series episode 11 (insulin icodec)  The Pharmacist's Voice ® Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacist's Voice ® Podcast episode 180, pronunciation series episode 9 Apretude® (cabotegravir) The Pharmacist's Voice ® Podcast episode 177, pronunciation series episode 8 (metoprolol)  The Pharmacist's Voice ® Podcast episode 164, pronunciation series episode 7 (levetiracetam) The Pharmacist's Voice ® Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC)  The Pharmacist's Voice ® Podcast episode 155, pronunciation series episode 5 Trulicity® (dulaglutide)  The Pharmacist's Voice ® Podcast episode 148, pronunciation series episode 4 Besponsa® (inotuzumab ozogamicin) The Pharmacist's Voice ® Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacist's Voice ® Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacist's Voice ® Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta   Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Get my FREE eBook and audiobook about podcasting ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com  ✅ Podcasting course https://www.kimnewlove.com/podcasting  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 339 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Jenny Armbruster, Executive Director of the non-profit, Prevent Ed, joins Chris and Amy as more locations in the St Louis region are receiving Narcan/Naloxone 'vending machines' to treat opioid overdoses.

Was the crowd into Shane Gillis's act at the ESPYs?; scary incident on the highway and speeding; vending machines for narcan in the region; Did you see this? Coldplay.

Chris and Amy talk about Naloxone vending machines; politics with Major Garrett; Jesse Rogers joins from ESPN to talk baseball; Amy wants to be part of a group; the great Lake Debate.

In July's episode of Chemical World, Kenna and Mugsy discuss upcoming events in August, the variety of places folks can access Naloxone in rural Colorado, and the importance of being prepared for Summer parties.

Naloxone has been available in Australia without prescription since 2022 (after pilot programs through 2019-2021, analysis showed this trial saved 3 lives per day). Join us as Kristin and Nat talk naloxone with Pharmacist Emily Turkovic. Emily shares her personal story and why she is passionate about ensuring that naloxone is widely available in our community. Listen in for tips and tricks on how to broach the subject with patients and ways to de-stigmatise naloxone. Resources: Opioid Safety Toolkit Free Take Home Naloxone training program Find out more about the Take Home Naloxone program here. Take Home Naloxone Program Resources

It's the tax-free weekend in Mississippi. What that means for families trying to save while making back to school purchases.Then, the first Naloxone vending machine in Mississippi is now open. Health officials say it will be a positive tool in curbing overdose deaths.Plus, community organizers say Black Women in Mississippi still get paid a fraction of their white male counterparts. Hosted on Acast. See acast.com/privacy for more information.

Overdose prevention starts before the crisis, with compassion, planning, and real-world tools that save lives upstream. In this episode, Sharlee Dixon sits down with Dr. Jorge Petit and Leah Harris from Zero Overdose, a national nonprofit dedicated to preventing overdose deaths through education, empowerment, and harm reduction. Dr. Jorge Petit, Strategy and Development Officer at Zero Overdose, brings over 30 years of experience in community and public psychiatry, advocating for people impacted by mental health and substance use. He has led major initiatives at Coordinated Behavioral Care and Beacon Health Options, and is the founder of Quality Healthcare Solutions. Leah Harris, a Trainer at Zero Overdose, draws on two decades of experience as a speaker and advocate, along with her own lived experience with substance use and recovery. She's worked with the Suicide Prevention Resource Center, NASMHPD, and PEERS to advance trauma-informed, person-centered approaches. Together, Jorge and Leah introduce the Overdose Safety Planning Specialist Training—a transformative program that equips providers, peers, and loved ones with the skills to assess and reduce overdose risks. Through frameworks, roleplay, and harm reduction strategies, the training empowers people to meet individuals where they are, without shame or stigma. We'll explore why this training is making waves across healthcare systems, how it centers lived experience, and why overdose prevention must be everyone's responsibility, from parents and providers to communities at large.   For more information about Zero Overdose, please visit: https://zerooverdose.org For more information about upcoming trainings and events, please visit: https://zerooverdose.org/services/ Connect with Zero Overdose on Instagram at: https://instagram.com/zerooverdose/ Connect with Zero Overdose on Linkedin at: https://www.linkedin.com/company/zero-overdose/ Connect with Zero Overdose on Facebook at: https://www.facebook.com/ZeroOverdoseOrg Connect with Zero Overdose on X at: https://twitter.com/zerooverdoseorg

Naloxone, a drug that counteracts the effects of opioid overdose, has become more available within Southeastern Nebraska. Free Naloxone can be found at three vending machines, as well as five grab-and-go sites located around Lincoln. There is also a grab-and-go site now located in Jansen, Southwest of Beatrice, near the Kansas border.

Next year's Pennsylvania gubernatorial race is already on the political horizon. So far, the Republican field is shaping up with three prominent figures expressing interest. EMTs could soon be authorized to give caregivers medication that would reverse opioid overdoses, as a bill is quickly moving through the state Capitol. Pennsylvania could receive as much as 200 million dollars as part of a massive settlement with drug maker Purdue Pharma. That's according to PA Attorney General Dave Sunday. The payout is part of a $7.4 billion deal, stemming from the opioid crisis, in which prosecutors and addiction experts say Purdue and its owners the Sackler family played a major role. A portion of land in Somerset County is now protected through a recent acquisition by The Nature Conservancy. The land is part of a critical ecosystem, and it's being added to State Game Lands 82. Police say an 18-year old stabbed his father to death with a machete-style knife during an early-morning argument Tuesday in their West York home. Raw milk sold in Lancaster County and throughout Central Pennsylvania is contaminated and should be thrown out, according to the Pennsylvania Department of Agriculture. The milk is contaminated with an infectious intestinal disease. The affected milk is Meadow View Jerseys brand raw milk purchased since April 1 with sell-by dates between April 15 and July 8. A Pennsylvania college is addressing its growing financial issues by auctioning its art collection. Albright College, located in Reading, Berks County - according to a report by our partners at Spotlight PA - is preparing to auction more than 2,000 pieces of art. Gov. Josh Shapiro was joined by Philadelphia Eagles Hall of Famer LeSean McCoy, at the official ribbon-cutting for a new 41-unit housing complex in Harrisburg, to benefit low and moderate income home buyers. And comedian and actor Shane Gillis, a Mechanicsburg native, will be hosting this year's ESPYS awards show. Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Drug overdose deaths have been increasing steadily for over two decades in large part due to opioids. That's until recently. Now, new data from the Centers for Disease Control found that 2024 saw the largest one year decline ever recorded. And that 24% decline was felt across the country. Every state except two saw a drop in overdose deaths. The drop comes after an aggressive public health response from both the Biden Administration and local efforts, including making the overdose reversing drug Naloxone available over the counter and in communities. But the crisis is far from over. Drug overdoses are still the leading cause of death for people aged 18 to 44. We discuss what we can we learn from looking at the recent decline in drug deaths and what federal cuts could mean for that progress. Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Hillsborough Mayor Mark Bell spoke with 97.9 The Hill's Andrew Stuckey on Tuesday, June 17, discussing town news and events. He told the story of seeing an incapacitated individual and calling first responders, who ultimately administered a life-saving dose of Naloxone. He talked about the need for more awareness around what to do in a situation like that, and the value of having overdose treatments available. He also discussed a recent assault in a a homeless encampment on the south side of Hillsborough. He also discussed upcoming community events and more. The post Hillsborough: Mayor Mark Bell Helps First Responders Save Overdose Victim appeared first on Chapelboro.com.

These days, you can get pretty much anything you want out of a vending machine, but they're also playing an important role in Boston's public health efforts. North End Waterfront Health is using these machines to provide basic necessities and harm-reduction supplies to people who are unhoused, low on cash, or navigating substance use. David Perry, Director of Substance Use Disorder Services, and Nadya Zaltsman, a recovery coach at NEW Health, are on the show this week to talk about the importance of low-barrier, judgment-free options to help people in need.

Around three dozen of her friends—that's how many lives Morgan Mentele believes have been saved thanks to Emily's Hope distributing free naloxone in the Sioux Falls, South Dakota area. In this powerful episode of Grieving Out Loud, Morgan courageously opens up about her journey: how she went from being a mom of two and Sunday School teacher to battling substance use disorder, how recovery finally became possible, and why she—and dozens of others—wouldn't be here today without the life-saving impact of Emily's Hope.You can find out where the Emily's Hope free naloxone boxes are located on the Emily's Hope website, along with information on how to use naloxone. Send us a textThe Emily's Hope Substance Use Prevention Curriculum has been carefully designed to address growing concerns surrounding substance use and overdose in our communities. Our curriculum focuses on age-appropriate and evidence-based content that educates children about the risks of substance use while empowering them to make healthy choices. Support the showConnect with Angela Follow Grieving Out Loud Follow Emily's Hope Read Angela's Blog Subscribe to Grieving Out Loud/Emily's Hope Updates Suggest a Guest For more episodes and information, just go to our website, emilyshope.charityWishing you faith, hope and courage!Podcast producers:Casey Wonnenberg King & Marley Miller

Tyler Carr gives his full review on the new Switch 2 from Nintendo!  Dave gives his review of Regina Saskatchewan, and The Energy Jet is back!  Candace Rae pops in for 'Dave Wheeler's Sports Opinion Read By His Wife Candace Rae'.Get the VIDEO VERSION of the Podcast HERE!!!! @TylerCarrfm@Energy106fmTyler Carr on Tik Tok

Melissa Magstadt, Secretary of Health for South Dakota and an ASTHO Member, explains the state's first-in-the-nation anonymous naloxone kit distribution program; Colton Anderson, ASTHO Senior Analyst for Public Health Infrastructure and Improvement, tells us about ASTHO's Quality Advisory Group; an ASTHO webinar scheduled for June 12 aims to help public health practitioners tell the story of public health; and Dr. Broke Cunningham, an ASTHO Member and the Commissioner of Health for the Minnesota Department of Health, will speak at the 2025 Minnesota Rural Health Conference. Emily's Hope News Release: Emily's Hope and South Dakota agencies team up to make lifesaving naloxone widely available ASTHO Blog Article: Quality Advisory Group Supports Performance Improvement in Health Agencies ASTHO Webinar: INSPIRE – Readiness - Tackling Public Health Communication Conundrums: Rumors and Public Trust Minnesota Rural Health Conference Web Page  

This week on Well Well Well, we explore the power of play and life-saving health interventions. Dr Phoebe Toups Dugas from Monash University joins us to discuss how games can be more than just entertainment—they can be spaces for identity exploration, community building, and inclusion for trans and queer players. We dive into what makes a game truly inclusive, how queer and trans gamers are shaping the future of game design, and why representation behind the scenes matters. Then, we turn our focus to harm reduction with Linda Cowan from Thorne Harbour Health, who breaks down everything you need to know about Naloxone—how it works, how to access it, and how this simple intervention can save lives in the face of Australia's ongoing overdose crisis. TGD Gaming Resources:  Published Papers: Designed & Discovered Euphoria: Insights from Trans-Femme Players' Experiences of Gender Euphoria in Video Games Analyzing Trans (Mis)Representation in Video Games to Remediate Gender Dysphoria Triggers Games Discussed: Celeste One night; hot springs Cyberpunk 2077 VA-11 Hall-A: Cyberpunk Bartender Action Easy, Free Development Platforms: Twine Godot Naloxone Resources: Sesh.ed (Instagram)Follow @sesh.ed for down-to-earth, non-stigmatising drug education and harm reduction info. Overdose DayLearn how to administer naloxone and access overdose prevention resources: overdoseday.com TripSit Drug Combinations ChartCheck drug interactions and potentially dangerous combinations with this easy-to-use chart: combo.tripsit.me Drug Alerts (Victoria)Stay informed with alerts from VicHealth and Sesh.ed. You can also get SMS alerts direct to your phone via Barwon Health: mhdas.barwonhealth.org.au Free Naloxone at PharmaciesAccess naloxone for free through Victoria's Take Home Naloxone program—no prescription needed: health.vic.gov.au – Naloxone Program

Une entreprise pharmaceutique de Saint-Hyacinthe propose une solution locale à la crise des surdoses : une naloxone prête à l’emploi, plus simple, plus sécuritaire, et fabriquée ici au Québec. Dans un contexte de dépendance aux produits importés, cette innovation pourrait sauver des vies tout en soutenant la production pharmaceutique locale. Pourquoi les provinces continuent-elles d’acheter ailleurs? Entrevue avec Bernard Bouchard, responsable du soutien clinique chez Sterinova Regardez aussi cette discussion en vidéo via https://www.qub.ca/videos ou en vous abonnant à QUB télé : https://www.tvaplus.ca/qub ou sur la chaîne Youtube QUB https://www.youtube.com/@qub_radioPour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

In the ongoing effort to reduce fentanyl-related deaths, the California government declared that the state will now sell the overdose medication Naloxone at a highly reduced price as part of Governor Newson's plan to lower the prices of prescription drugs. KCSB's Abbey Guerrero has the story.

In this episode of The Poison Lab, host Ryan Feldman is joined by Dr. Amy Zosel, a medical toxicologist, emergency physician, and educator. Together, they use real poisoning cases to practice identifying toxins and flexing their toxic differential The conversation dives into intriguing and challenging toxicology cases, with a focus on educating listeners about real-world poisoning scenarios, myth-busting internet misinformation, and providing practical clinical insights. Mini episode with Dr. Robert Bassett on Remembering Poisonous Mushrooms Dr. Zosel and Ryan discuss:14:15 Case 1 33:04 Case 2News story37:00 Case 3 New story48:00 Case 4 News storyUS outbreak "Robocough"Study about Naloxone in Clonidine overdose++Spoiler++: Below this will be key takeaways regarding managing the poisonings discussed, it may ruin your experience if you are guessing the poisons Key Takeaways:Amatoxin Mushroom Poisoning: The classic delayed onset of severe GI symptoms, followed by a latent phase, can mask progressive liver damage. Early recognition and treatment with hydration, silibinin, and possible liver transplant are critical.Tetramine Toxicity: Known for causing refractory seizures, tetramine is a rare but serious poisoning often requiring aggressive supportive care and anticonvulsants.A Lethal mushroom hiding in edible mushrooms Mushroom foraging dangerResources Mentioned:National Poison Control Hotline: 1-800-222-1222National Suicide Prevention Lifeline: 1-800-273-8255SAMHSA Free Helpline: 1-800-662-HELP (4357)Follow The Poison Lab:Twitter: @LabPoisonInstagram: @tox_talkWebsite: www.ThePoisonLab.comSubscribe and Review:Love what you're hearing? Help us reach more toxicology enthusiasts by leaving a review on Apple Podcasts, Spotify, or wherever you listen. Don't forget to share this episode with...

A Nashville convenience store installs a naloxone vending machine. Aldi plans to open more than 200 stores in 2025. And Walmart announces plans to remodel more than 650 stores in 47 states.

It's an overcast Saturday morning in late March and Station 20 West, located on 20th Street West and Avenue L South, is buzzing with activity.People have gathered to learn more about Naloxone, how to safely administer it to someone overdosing from opioids, and to talk about what can be done to help our community get through this difficult point in time.Saskatoon's drug and overdose crisis has been all over the news. A CBC story notes the Saskatoon Fire Department has responded to 935 overdose incidents or suspected opioid poisonings since the start of the year. That's compared to 376 incidents in the same time period last year.The Saskatoon Library closed two branches for a month over safety and overdose concerns, and Prairie Harm Reduction, which we have featured on the podcast several times, temporarily paused its operations in March to give its staff an opportunity to deal with the trauma they are seeing every day in our city. I think the local media and the Hard Knox Talks podcast have done an exemplarily job of telling the stories amidst this crisis, and I struggled to find a way to get into the crisis through the podcast. Then I learned about this gathering at Station 20 West and thought there might be some people who would be willing to share their stories. So my wife and I went on this Saturday morning and we met some pretty incredible people. We also learned how to administer Naloxone, which you will hear in this episode.We met Colleen Christopherson-Cote, Board Chair for Station 20 West, University of Saskatchewan doctoral candidate, Maryellen Gibson, and  Assistant Professor in the School of Public Health at the University of Saskatchewan, Barbara Fornssler. My sincere thanks to them for sharing their passion for helping others and their community in this episode. You can listen and follow YXE Underground wherever you find your favourite podcasts including Apple Podcasts, Spotify or on the website. Please feel free to leave a 5-star review if you like you what you hear. These reviews help the podcast get into more podcast feeds so I really do appreciate the support. Cheers...Eric  Host, Producer, Editor: Eric AndersonTheme Music: Andrew DicksonWebsite: https://www.yxeunderground.comRecorded: On Treaty 6 Territory and the traditional homeland of the Metis

In today's newscast, Monterey County supervisors and members of the public are frustrated at the slow pace of cleanup from the January battery plant fire in Moss Landing. And starting this week, Californians can buy the drug Naloxone at a discount on a state-run website.

The death of Pope Francis is being felt around the world. And right here in California, millions of Latino Catholics are mourning not just the loss of a spiritual leader, but someone who, for many, felt like one of their own. Pope Francis was the first from Latin America. He spoke often about immigration, inequality, and the dignity of the poor. Guest: Jeff Guhin, Sociology Professor, UCLA Starting this week, Californians can buy naloxone at a discount on a state-run website. Naloxone, also known as Narcan, is a drug used to reverse opioid overdoses. Reporter: Kristen Hwang, CalMatters A California state labor board says Governor Gavin Newsom may have violated the law when he issued an executive order calling state employees back into the office four days per week. Reporter: Megan Myscofski, CapRadio Learn more about your ad choices. Visit megaphone.fm/adchoices

Surgeon and author Jeffrey A. Singer discusses his article "The FDA's outdated prescription rules are failing women and opioid users." He argues that the U.S. Food and Drug Administration's requirement for prescriptions for certain safe medications, specifically hormonal contraceptives and the opioid antidote naloxone, creates significant barriers to access and reflects outdated paternalism. Jeffrey highlights that obtaining prescriptions for birth control pills adds cost and inconvenience, disproportionately affecting women who report difficulty accessing appointments, despite decades of recommendations from major medical groups like the American College of Obstetrics and Gynecology and the American Medical Association for over-the-counter access, a standard in over 100 countries. He critiques the FDA's slow and partial move to allow only one type of progestin-only "mini-pill" over-the-counter, contrasting it with the easier access to emergency contraception. Similarly, Jeffrey discusses the years-long delay in making naloxone available over-the-counter, despite its proven safety, effectiveness by laypeople, availability in other countries, and requests from experts and even the FDA itself, noting how manufacturer financial incentives and state-level workarounds preceded the eventual, partial FDA approval for the nasal spray form. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Send us a text In this powerful and deeply honest conversation, Melissa McGillivray and Jen Chouinard join me in the studio to share their lived experiences as service providers. Drawing on their expertise and personal insight, they break down the mental and emotional toll of working on the front lines of Saskatoon's overdose crisis.Through the lens of a registered nurse and a social worker/researcher, we explore the stark realities of substance use in the community, service provider burnout, compassion fatigue, moral injury, and the growing need for trauma-informed support—both for those experiencing addiction and for those offering care.

In this eye-opening episode we dive deep into the troubling intersection of the opioid epidemic and the pharmaceutical industry's influence. While Naloxone is marketed as a lifesaver, it's part of a larger cycle where the same companies that push opioids onto the market also profit from the treatments designed to counteract the very addiction they fueled. We'll explore exactly what you need to know about Naloxone and how to help you learn where your state is spending its opioid dollars. We will also discuss why short term solutions are the most lethal and learn how to approach addiction from a holistic and long term approach. Studies Referenced: https://www.kuer.org/health/2025-02-20/utah-counties-received-millions-to-battle-the-opioid-epidemic-many-havent-spent-a-dime More Living Proof: https://yourlivingproof.com Free Masterclass: https://yourlivingproof.com/free-masterclass Also available on Youtube: https://www.youtube.com/@your_living_proof

In this episode, hosts Dr. Jess Steier and Dr. Sarah Scheinman engage with Suhanee Mitragotri, a Harvard undergraduate and co-founder of the Naloxone Education Initiative, to discuss the opioid crisis in the United States. They explore the scale of the crisis, the importance of naloxone in reversing overdoses, and the gaps in education regarding opioids and harm reduction. The conversation emphasizes the need for increased awareness and education, particularly among youth, to combat the ongoing epidemic. Email Suhanee: suhaneemitragotri@college.harvard.edu https://steppingstrong.bwh.harvard.edu/naloxone-administration-program/ https://journalofethics.ama-assn.org/article/how-fda-failures-contributed-opioid-crisis/2020-08 https://pmc.ncbi.nlm.nih.gov/articles/PMC8154745/ https://www.fcc.gov/reports-research/maps/connect2health/focus-on-opioids.html https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html ----------------------------------------------------------------------------------------------------------------------- Interested in advertising with us? Please reach out to advertising@airwavemedia.com, with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices

For the latest and most important news of the day | https://www.thecanadianpressnews.ca To watch daily news videos, follow us on YouTube | https://www.youtube.com/@CdnPress The Canadian Press on X (formerly Twitter) | https://twitter.com/CdnPressNews The Canadian Press on LinkedIn | https://linkedin.com/showcase/98791543

The fight against the opioid crisis continues... and Utah has just surpassed an important milestone. Joining me live is Dr. Jennifer Plumb, medical director of Utah Naloxone.

In this episode of the Prehospital Care Research Forum's Journal Club, we discuss the findings of a qualitative study examining the acceptability of providing take-home naloxone kits by EMS to individuals at risk of opioid overdose. Discover the insights from the study, including patient perspectives, potential barriers, and the implications for overdose prevention strategies. Join us for a thought-provoking conversation on how EMS can play a pivotal role in combating the opioid crisis.https://www.tandfonline.com/doi/full/10.1080/10903127.2024.2435034?src=

Our speaker for the session is Summer Peregrin, PharmD, Ambulatory Clinical Pharmacist at Dignity Health Medical Group — Arizona, and one of the authors of the Opioid Toolkit for CommonSpirit Health.Learning ObjectivesReview the current state of the opioid epidemicRecognize signs and symptoms of a potential opioid overdoseBuild greater understanding of naloxone and its use to treat an opioid overdoseSummarize best practices in emergency response to an opioid overdosePanelistsShawna Sharp, RN, System Director Clinical Transformation, Physician EnterpriseMarijka Grey, MD, MBA, FACP, System Vice President Ambulatory Transformation & Innovation, Physician Enterprise

Additional resources to check out:April 22nd FREE Webinar (Noon-1pm CT) Registration: Naloxone Training: Responding to Opioid OverdoseSAMHSA's Overdose Prevention and Response Toolkit (see page 8 for common Opioid Overdose Reversal Medications available to the public, and page 18 for Appendix 1 and page 19 for Appendix 2)What is Naloxone? from the National Institute of HealthRecent drug overdose data - Drug Overdose Deaths in the United States, 2003–2023 from the CDC's National Center for Health StatisticsPrevent & Protect - This website is a free resource for opioid safety and opioid overdose prevention developed by public health and addiction medicine experts.The National Harm Reduction Coalition's Naloxone Finder - Harm reduction is a movement to reduce drug-related deaths and harmful consequences of drug use.-If you are interested in QPR training, visit: https://www.agrisafe.org/QPR/Sign up for the AgriSafe newsletter: https://www.agrisafe.org/newsletter/View upcoming webinars: https://www.agrisafe.org/events/-Directed by Laura SiegelHosted by Linda EmanuelEdited by Joel Sharpton for ProPodcastingServices.comSpecial Guest: Dr. Tara Haskins

This month, how films are helping neuroscientists link brain activity patterns to specific thought processes, a breakthrough in managing opiate overdose, a technique to study animal teamwork, extracting more information from brain scan data, and how childhood adversity blunts later fear responses... Get the references and the transcripts for this programme from the Naked Scientists website

Can reversing sedation be too much of a good thing? Flumazenil is a powerful benzodiazepine antagonist, but its use comes with both benefits and risks. In this episode of Everyday Oral Surgery, we welcome back Dr. Jake Stucki, a resident doctor at Case Western Reserve University School of Dental Medicine, to break down the benefits and drawbacks of flumazenil. In our conversation, we delve into the benefits, risks, cost considerations, and usage of flumazenil in oral surgery sedation. We explore using naloxone, its potential to reverse opioid effects, the associated costs of using it, and its potential for residual sedation. You'll also learn about the common misconceptions surrounding flumazenil, patient contraindications, guidelines on best practices, and more. Join us to learn about the fundamentals of flumazenil and how to use it effectively and safely in your practice with Dr. Jake Stucki. Tune in now!Key Points From This Episode:Learn about flumazenil's usage, its effects on patients, and why it is important.The associated costs, how it can be administered, and the correct dosage to use.Explore the benefits of flumazenil in oral surgery and patient recovery.  Uncover the potential risks surrounding re-sedation and other vital considerations.When not to use the drug and how it is commonly used in clinical practice.Find out about the downsides of using flumazenil and the complications it can cause.Hear about The Joint Commission's perspective on the use of flumazenil.Naloxone and how its usage and dosage are different from flumazenil.Discover an alternative approach for extracting maxillary upper third molars.Links Mentioned in Today's Episode:Dr. Jake Stucki on LinkedIn — https://www.linkedin.com/in/jake-stucki-ab19a593/  Case Western Reserve University School of Dental Medicine — https://case.edu/medicine/The Joint Commission — https://www.jointcommission.org/Dexter — https://www.imdb.com/title/tt0773262/Cobra Kai — https://www.imdb.com/title/tt7221388/Talking to Strangers — https://www.amazon.com/Talking-Strangers-Should-about-People/dp/0316478520/Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059

In this conversation, Von interviews April Ella, the director of operations at A New Path, a San Diego-based organization focused on harm reduction and advocacy for therapeutic drug policies. They discuss April's journey from fashion to harm reduction, the impact of fentanyl and the emerging drug Trank, the concept of harm reduction, the historical context of the war on drugs, and the importance of naloxone in preventing overdoses. April shares insights on the stigma surrounding addiction and the various services offered by A New Path to support individuals and families affected by substance use disorders.Chapters (00:00) Introduction to Harm Reduction and A New Path(04:47) April's Journey from Fashion to Harm Reduction(09:28) Understanding Fentanyl and Its Impact(17:26) The Myths and Realities of Fentanyl(21:37) Defining Harm Reduction in Drug Use(24:32) Personal Experiences and Harm Reduction Strategies(24:48) Harm Reduction in the Drug Community(27:33) Understanding Addiction as a Disease(30:27) The Need for Safe Consumption Sites(33:24) The War on Drugs: A Historical Perspective(39:20) The Ongoing Impact of Drug Policies (46:07) Reframing Addiction: A Public Health Issue(47:47) The Impact of Fear Mongering in the Drug War(52:42) Understanding Tranq: The New Drug on the Scene(55:59) Harm Reduction: A Bridge to Recovery(01:02:32) Naloxone: Saving Lives Through Education(01:11:07) A New Path: Community Services and Support https://linktr.ee/newpathnarcanproject https://www.instagram.com/newpathnarcanproject/Follow Me on Social Media: https://www.instagram.com/thevoncastshow/ https://www.instagram.com/shibavon/ https://www.iamvon.net/

In this episode Dr. Gillian Beauchamp sits down with Dr. Michael Toce to discuss naloxone access laws, increased community availability of naloxone and who still doesn't have access to naloxone. They also discuss the difference between naloxone and nalmefene and the future of nalmefene. 

(The Center Square) – With few solutions left, Spokane has banned single-serve alcohol sales downtown, as well as drug paraphernalia, unless the seller also provides free naloxone. The Spokane City Council gave its final approval over two related ordinances Monday night. The first established an Alcohol Impact Area, or AIA, within the Spokane Police Department's downtown precinct, while the second created a Community Health Impact Area, also known as CHIA. Support this podcast: https://secure.anedot.com/franklin-news-foundation/ce052532-b1e4-41c4-945c-d7ce2f52c38a?source_code=xxxxxx Read More: https://www.thecentersquare.com/washington/article_d8b98560-e330-11ef-ab6d-4f32aab83dca.html

Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky  Guest: Alex Elswick, PhD Extension Specialist for Substance Use Prevention and Recovery Season 7, Episode 31 In this episode of Talking FACS, host Mindy McCulley is joined by Dr. Alex Elswick, Extension Specialist for Substance Use Prevention and Recovery, to discuss Xylazine, a non-opioid sedative increasingly found in the drug supply. Originally used in veterinary medicine, Xylazine is not intended for human consumption but is being mixed with drugs like fentanyl without users' knowledge, complicating the ongoing opioid crisis. Dr. Elswick explains the unexpected presence of Xylazine in the drug market and its implications, highlighting how it poses new risks to overdose situations. The conversation delves into the difficulties posed by Xylazine's sedative effects, which can mask opioid overdoses and complicate life-saving interventions such as Naloxone administration. The episode also explores methods used to detect Xylazine presence in communities, including innovative wastewater analysis. As the discussion unfolds, listeners gain an understanding of the broader context of drug contamination and the pressing need for enhanced public awareness. Connect with FCS Extension through any of the links below for more information about any of the topics discussed on Talking FACS. Kentucky Extension Offices UK FCS Extension           Website           Facebook           Instagram           FCS Learning Channel

Deaths from fentanyl are falling. The promising news comes as the overdose antidote naloxone becomes more widely available. But are dropping death rates concealing other issues in the fight against this brutal form of addiction? Reuters Investigative Reporter Maurice Tamman joined The Excerpt to discuss what he's seeing on the ground where addiction and death are still the reality.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Podcast summary of articles from the December 2024 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include pulmonary embolism in COVID19 patients, intracranial bleeding, diltiazem in patients with heart failure, vital sign abnormalities, naloxone from the ED, and an interesting case report.  Guest speaker is Dr. Kinda Sweidan.

As we transition into a new administration, our hosts reflect on President Biden’s legacy in healthcare policy, focusing on three major areas that impacted patients: the COVID-19 response, the opioid crisis, and the Inflation Reduction Act. They discuss key achievements such as vaccine rollouts, reduced overdose deaths, and efforts to lower prescription drug costs, while also examining ongoing challenges and concerns. With the health policy landscape set to shift in 2025, this episode breaks down what patients need to know and how to stay engaged in advocacy for better care. Among the highlights in this episode: 00:40: Steven Newmark, Chief of Policy at GHLF, outlines three key areas where the Biden administration made a significant impact in health care: COVID-19 response, the opioid crisis, and the Inflation Reduction Act (IRA) 01:28: Steven highlights the Biden administration’s mass vaccination campaign, which saved an estimated 3.2 million American lives, according to the Commonwealth Fund 01:49: Zoe Rothblatt, Director of Community Outreach at GHLF, gives credit to Operation Warp Speed under Trump for fast-tracking vaccine development but emphasizes that the bulk of vaccinations happened under Biden 02:43: Zoe reflects on how the pandemic's threat level has changed, largely due to vaccines and continued booster developments 02:58: Steven shifts the discussion to the opioid crisis, explaining that overdose deaths were rising at 31% per year when Biden took office 03:35: Steven discusses how the administration's overdose prevention efforts led to a 14.5% decrease in overdose deaths — the largest reduction in U.S. history 04:17: Zoe explains how removing barriers to Naloxone access reduces response time during an overdose emergency 04:50: Steven discusses how Biden removed an outdated waiver requirement that expanded opioid treatment access by 15 times 06:11: Steven shifts focus to the IRA, explaining that it was one of Biden’s most significant health care policies 06:27: Zoe highlights a major win: capping Medicare Part D out-of-pocket prescription costs at $2,000 per year, down from $3,500 07:29: Steven explains why this is life-changing for seniors and people with disabilities, as many rely on multiple expensive medications 08:48: Zoe discusses the $35 monthly cap on insulin prices for Medicare patients, ensuring those with diabetes have affordable access to life-saving medication 09:11: Steven explains the potential downside of IRA’s Medicare drug price negotiations, which could reduce incentives for drug companies to develop new treatments 10:32: Zoe reminds listeners that with the upcoming presidential transition, health policies could change significantly, and GHLF will continue advocating for patient needs 11:01: Steven encourages listeners to join GHLF’s 50-State Network, stay informed, and share their stories to help shape health policies. Join GHLF’s 50 State Network, share your story, and get involved in advocacy to make a difference, email us at advocacy@ghlf.org Contact Our Hosts Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Director of Community Outreach at GHLF: zrothblatt@ghlf.org A podcast episode produced by Ben Blanc, Associate Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

In this conversation, Detective Patrick Craven discusses the alarming rise of fentanyl-related deaths among youth. We highlight the role of social media in facilitating drug transactions, the risks associated with experimentation, and the deceptive nature of counterfeit pills.  Patrick emphasizes the importance of parental awareness and education regarding the dangers of drug use in today's digital age. We provide essential guidance for parents on how to communicate the dangers of these substances to their children, the importance of being informed and proactive, and the life-saving potential of Naloxone. About Detective Patrick Craven Detective Patrick Craven is employed by the Placer County Sheriff's Office. Currently, he serves as the lead detective for the Placer Opioid Response Team (PORT), a specialized unit dedicated to addressing opioid-related issues. Before his role in PORT, Detective Craven spent four years as an undercover narcotics officer for the Placer County Special Investigation Unit (PSIU). In 2020, he began investigating fentanyl poisonings and has since been the lead detective on twenty-five cases involving fentanyl deaths. Detective Craven was the lead detective on California's first fentanyl poisoning homicide conviction as well as the state's second fentanyl poisoning homicide conviction by trial. In total, Detective Craven has successfully obtained three fentanyl poisoning homicide convictions and one manslaughter conviction. Detective Craven possesses unparalleled expertise in investigating fentanyl poisoning homicides and is leading the way in this specialized field. This episode is sponsored by Bark Technologies. Learn about the Bark Phone Learn about the Bark App for iPhones and Androids  *Use code SCROLLING2DEATH FOR 10% OFF Learn about the Bark Watch 

Host: Sarah Gray Guest: Chhari Attri Air date: Jan 09, 2025

Award-winning journalists Iris St. Meran and Christie Casciano bring Syracuse, New York's biggest stories to light, covering everything from government decisions to crime. This year, however, they encountered a crisis they couldn't simply cover from the newsroom.After repeatedly hearing overdose calls on the police scanner, they felt compelled to act. In addition to anchoring a special hour-long segment on the opioid crisis, the duo took their commitment a step further by completing naloxone training. Now equipped with the life-saving skills to administer Narcan, they're ready to help someone in the grip of an overdose.In this episode of Grieving Out Loud, hear how these journalists transitioned from reporting the news to potentially responding to the opioid epidemic.If you'd like to learn how to administer Narcan, watch this video to gain life-saving knowledge and discover more about Emily's Hope's mission to distribute naloxone to those in need.Watch the full special, More Than a Number: The Opioid Epidemic in Central New York, here: https://www.localsyr.com/more-than-a-number-the-opioid-epidemic-in-central-new-york/Awareness, Action, and Hope: Navigating the Opioid/Fentanyl crisis: https://www.drugfreeisuptome.org/Learn more about Narcan here: https://emilyshope.charity/narcan/Send us a textThe Emily's Hope Substance Use Prevention Curriculum has been carefully designed to address growing concerns surrounding substance use and overdose in our communities. Our curriculum focuses on age-appropriate and evidence-based content that educates children about the risks of substance use while empowering them to make healthy choices. Support the showFor more episodes and to read Angela's blog, just go to our website, emilyshope.charityWishing you faith, hope and courage! Podcast producers: Casey Wonnenberg & Kayli Fitz

Canadian journalist Nora Loreto reads the latest headlines for Monday, January 13, 2025.TRNN has partnered with Loreto to syndicate and share her daily news digest with our audience. Tune in every morning to the TRNN podcast feed to hear the latest important news stories from Canada and worldwide.Find more headlines from Nora at Sandy & Nora Talk Politics podcast feed.Help us continue producing radically independent news and in-depth analysis by following us and becoming a monthly sustainer.Sign up for our newsletterLike us on FacebookFollow us on TwitterDonate to support this podcast

Are high prices a barrier to preventing overdoses? Saliva may be the key to monitoring health. Do you feel fear? Learn More: https://radiohealthjournal.org/medical-notes-how-to-suppress-fear-why-your-saliva-matters-and-why-so-many-naloxone-prescriptions-are-unfilled Learn more about your ad choices. Visit megaphone.fm/adchoices

Finally, the journal club to rule ALL journal clubs. In this episode of The Poison Lab, we tackle one of the biggest topics in emergency medicine and toxicology: Should naloxone be given during opioid-associated cardiac arrest? With three fantastic studies published in 2024, we're diving into the data and hearing directly from the authors themselves.Join host Ryan Feldman as he interviews Dr. Eric Quinn, Dr. Joshua Lupton, and Dr. David Dillon, some of the minds behind the latest research exploring the role of naloxone in out-of-hospital cardiac arrest (OHCA). With perspectives ranging from clinical outcomes to practical implementation, this episode offers a deep dive into what these studies tell us—and what remains unanswered.But that's not all! Featuring special guests Spencer Oliver and Chris Pfingston from EMS 2020, this roundtable discussion incorporates the real-world insights of prehospital EMS professionals who face these decisions every day. Together, the panel unpacks:Conflicting evidence on naloxone's impact on ROSC and survival.The challenges of interpreting retrospective studies in a high-stakes setting.Ethical dilemmas surrounding randomized trials for naloxone.Practical considerations for paramedics and emergency physicians in the field.Whether you're a toxicologist, EMS professional, or just curious about the intersection of drugs, overdose, and resuscitation, this episode is packed with actionable insights, expert opinions, and engaging discussions.Tune in now to explore the science, controversy, and future directions for naloxone in cardiac arrest care!Studies discussed in the showOutcomes of Out-of-Hospital Cardiac Arrest Patients Who Receive Naloxone in an EMS System with a High Prevalence of Opioid Overdose – Dr. Eric Quinn.Association of Early Naloxone Use with Outcomes in Nonshockable Out-of-Hospital Cardiac Arrest – Dr. Joshua Lupton.Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrest in Northern California – Dr. David Dillon.Studies and guidelines mentioned Editorial by Dr. Lavonas on Dr. Lupton's study AHA 2023 Guidelines for poisoning cardiac arrestAHA 2021 Position statement on opioid overdose out of hospital cardiac arrest Study of opioid overdose death after bystander naloxone training mentioned by ToxoShows mentionedChris and Spencer's excellent EMS showRyan's Interview on Poisoning Cardiac Arrest Guidelines with Dr. Eric LavonasJournal club with Ryan and Dr. Dillon Timestamps and chaptersIntroduction (0:00–12:25)Podcast

Contributor: Aaron Lessen MD Educational Pearls: Can opioids cause cardiac arrest? Opioids can cause respiratory suppression and the subsequent low oxygen levels can lead to arrhythmias and eventually cardiac arrest. In 2023, 17% of out-of-hospital cardiac arrests (OHCA) were attributable to opioids. Given that this is a rising cause of cardiac arrest, should we just treat all cardiac arrest with naloxone (Narcan)? Naloxone is correlated with an increased chance of return of spontaneous circulation (ROSC) Additionally, a wide variety of individuals can be exposed to opioids and therefore opioid overdose should be considered in all cases of OHCA But does naloxone improve neurologic outcomes? Yes, naloxone, especially when given early on in the resuscitation can improve neuro outcomes What is the dose? 2-4 mg IN/IV depending on access. High suspicion for opioid overdose consider going with an even higher dose such as 4-8 mg IN/IV References Orkin, A. M., & Dezfulian, C. (2024). Recognizing the fastest growing cause of out-of-hospital cardiac arrest. Resuscitation, 198, 110206. https://doi.org/10.1016/j.resuscitation.2024.110206 Quinn, E., & Du Pont, D. (2024). Naloxone administration in out-of-hospital cardiac arrest: What's next?. Resuscitation, 201, 110307. https://doi.org/10.1016/j.resuscitation.2024.110307 Saybolt, M. D., Alter, S. M., Dos Santos, F., Calello, D. P., Rynn, K. O., Nelson, D. A., & Merlin, M. A. (2010). Naloxone in cardiac arrest with suspected opioid overdoses. Resuscitation, 81(1), 42–46. https://doi.org/10.1016/j.resuscitation.2009.09.016 Wampler D. A. (2024). Naloxone in Out-of-Hospital Cardiac Arrest-More Than Just Opioid Reversal. JAMA network open, 7(8), e2429131. https://doi.org/10.1001/jamanetworkopen.2024.29131 Summarized by Jeffrey Olson, MS3 | Edited by Meg Joyce MS1 & Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/

As emergency physicians, we are very familiar with giving naloxone to patients with concern for opioid overdose. Our EMS colleagues give naloxone all the time in the prehospital setting. We know it works well for patients who are obtained due to opioids, but what about for patients who have an out-of-hospital cardiac arrest? Our expert on todays episode, Dr. David Dillon, set out to find out.  Were you surprised by the findings in Dr. Dillon's study? Does it change your practice? Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Associate Professor of Emergency Medicine at UC Davis Guests: David Dillon, M.D., M.Phil., Ph.D, Assistant Professor of Emergency Medicine at UC Davis Resources: Dillon DG, Montoy JCC, Nishijima DK, Niederberger S, Menegazzi JJ, Lacocque J, Rodriguez RM, Wang RC. Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California. JAMA Netw Open. 2024 Aug 1;7(8):e2429154. *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.